Monoclonal antibodies (mAbs) are biological agents that are widely used to treat malignancies including non-Hodgkin's lymphomas and chronic lymphocytic leukaemia. The patents for many mAbs are expiring, so biosimilar medicines, which contain a version of the active ingredient of the original drug, are being developed.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Biosimilar Monoclonal Antibodies industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Infliximab
Rituximab
Trastuzumab
Adalimumab
Other
Market Segment by Product Application
Oncology
Autoimmune Disease
Other
Finally, the report provides detailed profile and data information analysis of leading company.
Celltrion
Pfizer (Hospira)
3SBIO
Novartis (Sandoz)
Dr Reddy's
Celgen Biopharma
Cadila Healthcare
Hisun Pharma
Torrent Pharmaceuticals
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Biosimilar Monoclonal Antibodies consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Biosimilar Monoclonal Antibodies market by identifying its various subsegments.
3.Focuses on the key global Biosimilar Monoclonal Antibodies manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Biosimilar Monoclonal Antibodies with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Biosimilar Monoclonal Antibodies submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Biosimilar Monoclonal Antibodies Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Biosimilar Monoclonal Antibodies Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Biosimilar Monoclonal Antibodies Segment by Type
2.1.1 Infliximab
2.1.2 Rituximab
2.1.3 Trastuzumab
2.1.4 Adalimumab
2.1.5 Other
2.2 Market Analysis by Application
2.2.1 Oncology
2.2.2 Autoimmune Disease
2.2.3 Other
2.3 Global Biosimilar Monoclonal Antibodies Market Comparison by Regions (2017-2027)
2.3.1 Global Biosimilar Monoclonal Antibodies Market Size (2017-2027)
2.3.2 North America Biosimilar Monoclonal Antibodies Status and Prospect (2017-2027)
2.3.3 Europe Biosimilar Monoclonal Antibodies Status and Prospect (2017-2027)
2.3.4 China Biosimilar Monoclonal Antibodies Status and Prospect (2017-2027)
2.3.5 Japan Biosimilar Monoclonal Antibodies Status and Prospect (2017-2027)
2.3.6 Southeast Asia Biosimilar Monoclonal Antibodies Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Biosimilar Monoclonal Antibodies Industry Impact
2.5.1 Biosimilar Monoclonal Antibodies Business Impact Assessment - Covid-19
2.5.2 Market Trends and Biosimilar Monoclonal Antibodies Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Biosimilar Monoclonal Antibodies Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Biosimilar Monoclonal Antibodies Manufacturer Market Share
3.5 Top 10 Biosimilar Monoclonal Antibodies Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Biosimilar Monoclonal Antibodies Market
3.7 Key Manufacturers Biosimilar Monoclonal Antibodies Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Biosimilar Monoclonal Antibodies Industry Key Manufacturers
4.1 Celltrion
4.1.1 Compan Detail
4.1.2 Celltrion Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
4.1.3 Celltrion 139 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Celltrion News
4.2 Pfizer (Hospira)
4.2.1 Compan Detail
4.2.2 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
4.2.3 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Celltrion News
4.3 3SBIO
4.3.1 Compan Detail
4.3.2 3SBIO Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
4.3.3 3SBIO Biosimilar Monoclonal Antibodies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 3SBIO News
4.4 Novartis (Sandoz)
4.4.1 Compan Detail
4.4.2 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
4.4.3 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Novartis (Sandoz) News
4.5 Dr Reddy's
4.5.1 Compan Detail
4.5.2 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
4.5.3 Dr Reddy's Biosimilar Monoclonal Antibodies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Dr Reddy's News
4.6 Celgen Biopharma
4.6.1 Compan Detail
4.6.2 Celgen Biopharma Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
4.6.3 Celgen Biopharma Biosimilar Monoclonal Antibodies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Celgen Biopharma News
4.7 Cadila Healthcare
4.7.1 Compan Detail
4.7.2 Cadila Healthcare Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
4.7.3 Cadila Healthcare Biosimilar Monoclonal Antibodies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Hisun Pharma
4.8.1 Compan Detail
4.8.2 Hisun Pharma Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
4.8.3 Hisun Pharma Biosimilar Monoclonal Antibodies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Hisun Pharma News
4.9 Torrent Pharmaceuticals
4.9.1 Compan Detail
4.9.2 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification
4.9.3 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Torrent Pharmaceuticals News
5 Global Biosimilar Monoclonal Antibodies Market Segment by Big Type
5.1 Global Biosimilar Monoclonal Antibodies Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Big Type (2017-2022)
5.2 Infliximab Sales Growth Rate and Price
5.2.1 Global Infliximab Sales Growth Rate (2017-2022)
5.2.2 Global Infliximab Price (2017-2022)
5.3 Rituximab Sales Growth Rate and Price
5.3.1 Global Rituximab Sales Growth Rate (2017-2022)
5.3.2 Global Rituximab Price (2017-2022)
5.4 Trastuzumab Sales Growth Rate and Price
5.4.1 Global Trastuzumab Sales Growth Rate (2017-2022)
5.4.2 Global Trastuzumab Price (2017-2022)
5.5 Adalimumab Sales Growth Rate and Price
5.5.1 Global Adalimumab Sales Growth Rate (2017-2022)
5.5.2 Global Adalimumab Price (2017-2022)
5.6 Other Sales Growth Rate and Price
5.6.1 Global Other Sales Growth Rate (2017-2022)
5.6.2 Global Other Price (2017-2022)
6 Global Biosimilar Monoclonal Antibodies Market Segment by Big Application
6.1 Global Biosimilar Monoclonal Antibodies Sales Market Share by Big Application (2017-2022)
6.2 Oncology Sales Growth Rate (2017-2022)
6.3 Autoimmune Disease Sales Growth Rate (2017-2022)
6.4 Other Sales Growth Rate (2017-2022)
7 Global Biosimilar Monoclonal Antibodies Forecast
7.1 Global Biosimilar Monoclonal Antibodies Revenue, Sales and Growth Rate (2022-2027)
7.2 Biosimilar Monoclonal Antibodies Market Forecast by Regions (2022-2027)
7.2.1 North America Biosimilar Monoclonal Antibodies Market Forecast (2022-2027)
7.2.2 Europe Biosimilar Monoclonal Antibodies Market Forecast (2022-2027)
7.2.3 China Biosimilar Monoclonal Antibodies Market Forecast (2022-2027)
7.2.4 Japan Biosimilar Monoclonal Antibodies Market Forecast (2022-2027)
7.2.5 Southeast Asia Biosimilar Monoclonal Antibodies Market Forecast (2022-2027)
7.2.6 Other Regions Biosimilar Monoclonal Antibodies Market Forecast (2022-2027)
7.3 Biosimilar Monoclonal Antibodies Market Forecast by Type (2022-2027)
7.3.1 Global Biosimilar Monoclonal Antibodies Sales Forecast by Type (2022-2027)
7.3.2 Global Biosimilar Monoclonal Antibodies Market Share Forecast by Type (2022-2027)
7.4 Biosimilar Monoclonal Antibodies Market Forecast by Application (2022-2027)
7.4.1 Global Biosimilar Monoclonal Antibodies Sales Forecast by Application (2022-2027)
7.4.2 Global Biosimilar Monoclonal Antibodies Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Biosimilar Monoclonal Antibodies Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Biosimilar Monoclonal Antibodies Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Biosimilar Monoclonal Antibodies
Figure Market Concentration Ratio and Market Maturity Analysis of Biosimilar Monoclonal Antibodies
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Biosimilar Monoclonal Antibodies Market Size by Big Type
Figure Global Market Share of Biosimilar Monoclonal Antibodies by Big Type in 2021
Figure Infliximab Picture (2017-2022)
Figure Rituximab Picture (2017-2022)
Figure Trastuzumab Picture (2017-2022)
Figure Adalimumab Picture (2017-2022)
Global Biosimilar Monoclonal Antibodies Market Size by Big Application
Table Global Biosimilar Monoclonal Antibodies Market Size by Application
Figure Global Biosimilar Monoclonal Antibodies Market Share by Big Application in 2021
Figure Oncology Picture
Figure Autoimmune Disease Picture
Figure Other Picture
Table Global Biosimilar Monoclonal Antibodies Comparison by Regions (M USD) (2017-2027)
Figure Global Biosimilar Monoclonal Antibodies Market Size (Million US$) (2017-2027)
Figure North America Biosimilar Monoclonal Antibodies Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Biosimilar Monoclonal Antibodies Revenue (Million US$) Growth Rate (2017-2027)
Figure China Biosimilar Monoclonal Antibodies Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Biosimilar Monoclonal Antibodies Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Biosimilar Monoclonal Antibodies Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Biosimilar Monoclonal Antibodies Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Biosimilar Monoclonal Antibodies Sales by Manufacturer (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Manufacturer in 2021
Table Global Biosimilar Monoclonal Antibodies Revenue by Manufacturer (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Manufacturer in 2021
Table Global Biosimilar Monoclonal Antibodies Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Biosimilar Monoclonal Antibodies Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Biosimilar Monoclonal Antibodies Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Biosimilar Monoclonal Antibodies Market
Table Key Manufacturers Biosimilar Monoclonal Antibodies Product Type
Table Mergers & Acquisitions Planning
Table Celltrion Company Profile
Table Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification of Celltrion
Table Biosimilar Monoclonal Antibodies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Pfizer (Hospira) Company Profile
Table Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification of Pfizer (Hospira)
Table Biosimilar Monoclonal Antibodies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Pfizer (Hospira) Recent Development
Table 3SBIO Company Profile
Table Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification of 3SBIO
Table Biosimilar Monoclonal Antibodies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table 3SBIO Main Business
Table 3SBIO Recent Development
Table Novartis (Sandoz) Company Profile
Table Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification of Novartis (Sandoz)
Table Biosimilar Monoclonal Antibodies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Novartis (Sandoz) Main Business
Table Novartis (Sandoz) Recent Development
Table Novartis (Sandoz) Main Business
Table Novartis (Sandoz) Recent Development
Table Dr Reddy's Company Profile
Table Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification of Dr Reddy's
Table Biosimilar Monoclonal Antibodies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Dr Reddy's Main Business
Table Dr Reddy's Recent Development
Table Celgen Biopharma Company Profile
Table Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification of Celgen Biopharma
Table Biosimilar Monoclonal Antibodies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Celgen Biopharma Main Business
Table Celgen Biopharma Recent Development
Table Cadila Healthcare Company Profile
Table Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification of Cadila Healthcare
Table Biosimilar Monoclonal Antibodies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Cadila Healthcare Main Business
Table Cadila Healthcare Recent Development
Table Hisun Pharma Company Profile
Table Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification of Hisun Pharma
Table Biosimilar Monoclonal Antibodies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Hisun Pharma Main Business
Table Hisun Pharma Recent Development
Table Torrent Pharmaceuticals Company Profile
Table Biosimilar Monoclonal Antibodies Product Introduction, Application and Specification of Torrent Pharmaceuticals
Table Biosimilar Monoclonal Antibodies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Torrent Pharmaceuticals Main Business
Table Torrent Pharmaceuticals Recent Development
Figure Global Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2022)
Table Global Biosimilar Monoclonal Antibodies Sales by Regions (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Regions in 2021
Table Global Biosimilar Monoclonal Antibodies Revenue by Regions (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Regions in 2021
Figure North America Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
Figure Europe Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
Figure China Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
Figure Japan Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
Figure Southeast Asia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
Figure Other Regions Biosimilar Monoclonal Antibodies Sales and Growth Rate (2017-2022)
Table Global Biosimilar Monoclonal Antibodies Sales by Big Type (2017-2022)
Table Global Biosimilar Monoclonal Antibodies Sales Market Share by Big Type (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Big Type in 2019
Table Global Biosimilar Monoclonal Antibodies Revenue by Big Type (2017-2022)
Table Global Biosimilar Monoclonal Antibodies Revenue Market Share by Big Type (2017-2022)
Table Global Biosimilar Monoclonal Antibodies Revenue Market Share by Big Type in 2019
Figure Global Infliximab Sales Growth Rate (2017-2022)
Figure Global Infliximab Price (2017-2022)
Figure Global Rituximab Sales Growth Rate (2017-2022)
Figure Global Rituximab Price (2017-2022)
Figure Global Trastuzumab Sales Growth Rate (2017-2022)
Figure Global Trastuzumab Price (2017-2022)
Figure Global Adalimumab Sales Growth Rate (2017-2022)
Figure Global Adalimumab Price (2017-2022)
Table Global Biosimilar Monoclonal Antibodies Sales by Big Application (2017-2022)
Table Global Biosimilar Monoclonal Antibodies Sales Market Share by Big Application (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Big Application in 2019
Figure Global Oncology Sales Growth Rate (2017-2022)
Figure Global Autoimmune Disease Sales Growth Rate (2017-2022)
Figure Global Other Sales Growth Rate (2017-2022)
Figure Global Biosimilar Monoclonal Antibodies Sales and Growth Rate (2022-2027)
Figure Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2022-2027)
Table Global Biosimilar Monoclonal Antibodies Sales Forecast by Regions (2022-2027)
Table Global Biosimilar Monoclonal Antibodies Market Share Forecast by Regions (2022-2027)
Figure North America Sales Biosimilar Monoclonal Antibodies Market Forecast (2022-2027)
Figure Europe Sales Biosimilar Monoclonal Antibodies Market Forecast (2022-2027)
Figure China Sales Biosimilar Monoclonal Antibodies Market Forecast (2022-2027)
Figure Japan Sales Biosimilar Monoclonal Antibodies Market Forecast (2022-2027)
Figure Southeast Asia Sales Biosimilar Monoclonal Antibodies Market Forecast (2022-2027)
Figure Other Regions Sales Biosimilar Monoclonal Antibodies Market Forecast (2022-2027)
Table Global Biosimilar Monoclonal Antibodies Sales Forecast by Type (2022-2027)
Table Global Biosimilar Monoclonal Antibodies Market Share Forecast by Type (2022-2027)
Table Global Biosimilar Monoclonal Antibodies Sales Forecast by Application (2022-2027)
Table Global Biosimilar Monoclonal Antibodies Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilar Monoclonal Antibodies
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Biosimilar Monoclonal Antibodies Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Biosimilar Monoclonal Antibodies Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Biosimilar Monoclonal Antibodies Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Biosimilar Monoclonal Antibodies Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Biosimilar Monoclonal Antibodies Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Biosimilar Monoclonal Antibodies Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Biosimilar Monoclonal Antibodies Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Biosimilar Monoclonal Antibodies Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Celltrion
Pfizer (Hospira)
3SBIO
Novartis (Sandoz)
Dr Reddy's
Celgen Biopharma
Cadila Healthcare
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)